10/29/2024 | Needham & Company LLC | Reiterated Rating | Hold | | |
10/17/2024 | BMO Capital Markets | Lower Target | Market Perform ➝ Market Perform | $128.00 ➝ $114.00 | |
10/10/2024 | Raymond James | Reiterated Rating | Outperform | $155.00 | |
10/4/2024 | Royal Bank of Canada | Lower Target | Sector Perform ➝ Sector Perform | $136.00 ➝ $133.00 | |
9/16/2024 | Cantor Fitzgerald | Reiterated Rating | Overweight ➝ Overweight | $155.00 ➝ $155.00 | |
9/9/2024 | Barclays | Lower Target | Overweight ➝ Overweight | $180.00 ➝ $160.00 | |
8/29/2024 | Cantor Fitzgerald | Lower Target | Overweight ➝ Overweight | $170.00 ➝ $155.00 | |
8/29/2024 | Royal Bank of Canada | Lower Target | Sector Perform ➝ Sector Perform | $143.00 ➝ $136.00 | |
8/29/2024 | BMO Capital Markets | Lower Target | Market Perform ➝ Market Perform | $142.00 ➝ $128.00 | |
8/29/2024 | Needham & Company LLC | Reiterated Rating | Hold | | |
8/29/2024 | HC Wainwright | Reiterated Rating | Buy ➝ Buy | $190.00 ➝ $190.00 | |
8/29/2024 | Piper Sandler | Upgrade | Neutral ➝ Overweight | $131.00 ➝ $159.00 | |
8/19/2024 | Jefferies Financial Group | Boost Target | Buy ➝ Buy | $177.00 ➝ $189.00 | |
8/7/2024 | JPMorgan Chase & Co. | Boost Target | Overweight ➝ Overweight | $173.00 ➝ $181.00 | |
8/5/2024 | HC Wainwright | Boost Target | Buy ➝ Buy | $160.00 ➝ $190.00 | |
8/2/2024 | Royal Bank of Canada | Boost Target | Sector Perform ➝ Sector Perform | $136.00 ➝ $143.00 | |
8/2/2024 | Guggenheim | Boost Target | Buy ➝ Buy | $170.00 ➝ $180.00 | |
8/2/2024 | Oppenheimer | Boost Target | Outperform ➝ Outperform | $216.00 ➝ $219.00 | |
8/2/2024 | Citigroup | Boost Target | Neutral ➝ Neutral | $150.00 ➝ $158.00 | |
8/2/2024 | Barclays | Boost Target | Overweight ➝ Overweight | $169.00 ➝ $180.00 | |
8/2/2024 | Robert W. Baird | Boost Target | Outperform ➝ Outperform | $157.00 ➝ $180.00 | |
8/1/2024 | Needham & Company LLC | Reiterated Rating | Hold | | |
7/25/2024 | Cantor Fitzgerald | Reiterated Rating | Overweight ➝ Overweight | $155.00 ➝ $155.00 | |
7/25/2024 | Needham & Company LLC | Reiterated Rating | Hold | | |
7/12/2024 | Morgan Stanley | Boost Target | Overweight ➝ Overweight | $160.00 ➝ $170.00 | |
7/10/2024 | JPMorgan Chase & Co. | Boost Target | Overweight ➝ Overweight | $169.00 ➝ $173.00 | |
6/12/2024 | Morgan Stanley | Reiterated Rating | Overweight ➝ Overweight | $160.00 ➝ $160.00 | |
5/29/2024 | Wedbush | Reiterated Rating | Outperform ➝ Outperform | $152.00 ➝ $152.00 | |
5/28/2024 | UBS Group | Boost Target | Buy ➝ Buy | $174.00 ➝ $193.00 | |
5/14/2024 | Evercore ISI | Initiated Coverage | Outperform | $175.00 | |
5/13/2024 | Evercore ISI | Upgrade | Strong-Buy | | |
5/3/2024 | Citigroup | Boost Target | Neutral ➝ Neutral | $140.00 ➝ $150.00 | |
5/2/2024 | Canaccord Genuity Group | Boost Target | Buy ➝ Buy | $154.00 ➝ $164.00 | |
5/2/2024 | Guggenheim | Boost Target | Buy ➝ Buy | $164.00 ➝ $170.00 | |
5/2/2024 | Barclays | Boost Target | Overweight ➝ Overweight | $150.00 ➝ $169.00 | |
5/2/2024 | BMO Capital Markets | Boost Target | Market Perform ➝ Market Perform | $129.00 ➝ $138.00 | |
5/2/2024 | Oppenheimer | Boost Target | Outperform ➝ Outperform | $200.00 ➝ $216.00 | |
5/2/2024 | HC Wainwright | Boost Target | Buy ➝ Buy | $150.00 ➝ $160.00 | |
5/1/2024 | Needham & Company LLC | Reiterated Rating | Hold | | |
4/24/2024 | HC Wainwright | Reiterated Rating | Buy ➝ Buy | $150.00 | |
4/24/2024 | Oppenheimer | Reiterated Rating | Outperform ➝ Outperform | $200.00 ➝ $200.00 | |
4/24/2024 | Wells Fargo & Company | Upgrade | Equal Weight ➝ Overweight | $140.00 ➝ $170.00 | |
4/23/2024 | Needham & Company LLC | Reiterated Rating | Hold | | |
4/17/2024 | Wedbush | Reiterated Rating | Outperform ➝ Outperform | $147.00 | |
4/10/2024 | Cantor Fitzgerald | Reiterated Rating | Overweight ➝ Overweight | $155.00 | |
3/20/2024 | JPMorgan Chase & Co. | Boost Target | Overweight ➝ Overweight | $148.00 ➝ $158.00 | |
2/23/2024 | JPMorgan Chase & Co. | Lower Target | Overweight ➝ Overweight | $154.00 ➝ $148.00 | |
2/8/2024 | Citigroup | Lower Target | Neutral ➝ Neutral | $141.00 ➝ $140.00 | |
2/8/2024 | Mizuho | Boost Target | Neutral ➝ Neutral | $116.00 ➝ $140.00 | |
2/8/2024 | Wells Fargo & Company | Boost Target | Equal Weight ➝ Equal Weight | $127.00 ➝ $140.00 | |
1/25/2024 | The Goldman Sachs Group | Boost Target | Buy ➝ Buy | $134.00 ➝ $153.00 | |
1/23/2024 | Barclays | Boost Target | Overweight ➝ Overweight | $145.00 ➝ $150.00 | |
12/18/2023 | Stifel Nicolaus | Boost Target | Buy ➝ Buy | $141.00 ➝ $144.00 | |
12/13/2023 | Wells Fargo & Company | Boost Target | Equal Weight ➝ Equal Weight | $110.00 ➝ $127.00 | |
12/13/2023 | Citigroup | Initiated Coverage | Neutral | $127.00 | |
12/12/2023 | Deutsche Bank Aktiengesellschaft | Initiated Coverage | Buy | $136.00 | |
12/7/2023 | Canaccord Genuity Group | Reiterated Rating | Buy ➝ Buy | $150.00 | |
11/10/2023 | Mizuho | Lower Target | Neutral ➝ Neutral | $116.00 ➝ $114.00 | |
11/10/2023 | Royal Bank of Canada | Lower Target | Sector Perform ➝ Sector Perform | $128.00 ➝ $121.00 | |
11/10/2023 | BMO Capital Markets | Lower Target | Market Perform ➝ Market Perform | $111.00 ➝ $100.00 | |
11/3/2023 | Mizuho | Boost Target | Neutral ➝ Neutral | $113.00 ➝ $116.00 | |
11/1/2023 | Piper Sandler | Boost Target | Neutral ➝ Neutral | $95.00 ➝ $100.00 | |
11/1/2023 | Royal Bank of Canada | Boost Target | Sector Perform ➝ Sector Perform | $123.00 ➝ $128.00 | |
11/1/2023 | Raymond James | Boost Target | Outperform ➝ Outperform | $135.00 ➝ $145.00 | |
10/24/2023 | Cantor Fitzgerald | Reiterated Rating | Overweight | | |
10/8/2023 | Bank of America | Boost Target | | $137.00 ➝ $143.00 | |
10/6/2023 | Leerink Partners | Boost Target | | $125.00 ➝ $135.00 | |
10/6/2023 | Robert W. Baird | Boost Target | | $152.00 ➝ $157.00 | |
10/6/2023 | Oppenheimer | Boost Target | Outperform ➝ Outperform | $160.00 ➝ $165.00 | |
10/6/2023 | HC Wainwright | Boost Target | Buy ➝ Buy | $146.00 ➝ $150.00 | |
9/21/2023 | Barclays | Boost Target | | $125.00 ➝ $134.00 | |
9/13/2023 | Mizuho | Reiterated Rating | Neutral ➝ Neutral | $113.00 | |
9/13/2023 | Canaccord Genuity Group | Boost Target | Buy ➝ Buy | $132.00 ➝ $144.00 | |
9/13/2023 | Robert W. Baird | Boost Target | | $148.00 ➝ $152.00 | |
9/13/2023 | HC Wainwright | Reiterated Rating | Buy ➝ Buy | $146.00 | |
9/13/2023 | Cantor Fitzgerald | Reiterated Rating | Overweight ➝ Overweight | $136.00 | |
9/13/2023 | JPMorgan Chase & Co. | Boost Target | Overweight ➝ Overweight | $133.00 ➝ $134.00 | |
9/13/2023 | Wedbush | Boost Target | Outperform ➝ Outperform | $120.00 ➝ $137.00 | |
9/13/2023 | BMO Capital Markets | Boost Target | Market Perform ➝ Market Perform | $100.00 ➝ $111.00 | |
8/22/2023 | Cantor Fitzgerald | Reiterated Rating | Overweight ➝ Overweight | $136.00 | |
8/21/2023 | Mizuho | Boost Target | Neutral | $112.00 ➝ $113.00 | |
8/21/2023 | Jefferies Financial Group | Boost Target | | $123.00 | |
8/21/2023 | Oppenheimer | Boost Target | Outperform ➝ Outperform | $150.00 ➝ $154.00 | |
8/21/2023 | HC Wainwright | Boost Target | Buy ➝ Buy | $140.00 ➝ $146.00 | |
8/2/2023 | Oppenheimer | Reiterated Rating | Outperform ➝ Outperform | $150.00 | |
8/2/2023 | BMO Capital Markets | Boost Target | Market Perform ➝ Market Perform | $96.00 ➝ $100.00 | |
8/2/2023 | Morgan Stanley | Reiterated Rating | Overweight ➝ Overweight | $130.00 | |
8/2/2023 | Royal Bank of Canada | Boost Target | Sector Perform ➝ Sector Perform | $108.00 ➝ $110.00 | |
8/2/2023 | HC Wainwright | Reiterated Rating | Buy ➝ Buy | $140.00 | |
8/2/2023 | Canaccord Genuity Group | Boost Target | Buy ➝ Buy | $130.00 ➝ $132.00 | |
8/2/2023 | Cantor Fitzgerald | Boost Target | | $127.00 ➝ $135.00 | |
8/2/2023 | Mizuho | Boost Target | Neutral ➝ Neutral | $111.00 ➝ $112.00 | |
8/2/2023 | Robert W. Baird | Boost Target | Outperform ➝ Outperform | $140.00 ➝ $148.00 | |
7/24/2023 | Leerink Partners | Upgrade | Market Perform ➝ Outperform | | |
7/24/2023 | SVB Securities | Upgrade | Market Perform ➝ Outperform | $115.00 ➝ $125.00 | |
7/6/2023 | BMO Capital Markets | Upgrade | Underperform ➝ Market Perform | $91.00 ➝ $96.00 | |
6/30/2023 | Royal Bank of Canada | Reiterated Rating | Sector Perform ➝ Sector Perform | $108.00 | |
6/6/2023 | Stifel Nicolaus | Lower Target | | $145.00 ➝ $125.00 | |
6/5/2023 | Royal Bank of Canada | Boost Target | | $106.00 ➝ $108.00 | |
5/4/2023 | Mizuho | Lower Target | | $116.00 ➝ $111.00 | |
5/4/2023 | Citigroup | Lower Target | | $127.00 ➝ $122.00 | |
5/4/2023 | Barclays | Lower Target | | $131.00 ➝ $125.00 | |
5/4/2023 | Guggenheim | Upgrade | Neutral ➝ Buy | $145.00 | |
4/24/2023 | Royal Bank of Canada | Boost Target | | $108.00 ➝ $110.00 | |
4/19/2023 | Citigroup | Lower Target | Buy | $131.00 ➝ $127.00 | |
4/17/2023 | Wedbush | Lower Target | Outperform | $131.00 ➝ $128.00 | |
4/14/2023 | Mizuho | Reiterated Rating | Neutral | $116.00 | |
4/4/2023 | UBS Group | Lower Target | Buy | $137.00 ➝ $125.00 | |
3/30/2023 | Canaccord Genuity Group | Upgrade | Hold ➝ Buy | $124.00 ➝ $132.00 | |
3/3/2023 | Evercore ISI | Upgrade | In-Line ➝ Outperform | $130.00 | |
2/7/2023 | Royal Bank of Canada | Lower Target | Sector Perform | $122.00 ➝ $110.00 | |
2/7/2023 | Wells Fargo & Company | Lower Target | Equal Weight | $120.00 ➝ $115.00 | |
2/7/2023 | HC Wainwright | Reiterated Rating | Buy | $140.00 | |
2/7/2023 | Mizuho | Reiterated Rating | Neutral | $116.00 | |
2/7/2023 | Cantor Fitzgerald | Lower Target | Overweight | $132.00 ➝ $127.00 | |
2/7/2023 | Wedbush | Boost Target | Outperform | $125.00 ➝ $131.00 | |
2/7/2023 | Citigroup | Lower Target | Buy | $133.00 ➝ $131.00 | |
2/7/2023 | Barclays | Lower Target | Overweight | $136.00 ➝ $131.00 | |
2/7/2023 | Piper Sandler | Lower Target | Neutral | $103.00 ➝ $95.00 | |
2/3/2023 | Morgan Stanley | Upgrade | Equal Weight ➝ Overweight | $120.00 ➝ $130.00 | |
11/3/2022 | Raymond James | Boost Target | Outperform | $125.00 ➝ $135.00 | |
11/3/2022 | JPMorgan Chase & Co. | Boost Target | Overweight | $138.00 ➝ $143.00 | |
11/2/2022 | Mizuho | Boost Target | Neutral | $105.00 ➝ $116.00 | |
11/2/2022 | BMO Capital Markets | Boost Target | | $78.00 ➝ $101.00 | |
11/2/2022 | Morgan Stanley | Boost Target | Equal Weight | $102.00 ➝ $120.00 | |
11/2/2022 | Wells Fargo & Company | Boost Target | Equal Weight | $110.00 ➝ $120.00 | |
11/2/2022 | Royal Bank of Canada | Boost Target | Sector Perform | $101.00 ➝ $117.00 | |
11/2/2022 | Cantor Fitzgerald | Boost Target | Overweight | $127.00 ➝ $132.00 | |
11/2/2022 | Robert W. Baird | Boost Target | | $125.00 ➝ $150.00 | |
11/2/2022 | Piper Sandler | Boost Target | Neutral | $91.00 ➝ $103.00 | |
11/2/2022 | Leerink Partners | Boost Target | Market Perform | $100.00 ➝ $115.00 | |
10/24/2022 | Citigroup | Boost Target | Buy | $114.00 ➝ $128.00 | |
10/20/2022 | Mizuho | Boost Target | Neutral | $98.00 ➝ $105.00 | |
10/11/2022 | UBS Group | Initiated Coverage | Buy | $136.00 | |
9/26/2022 | Wells Fargo & Company | Initiated Coverage | Equal Weight | $110.00 | |
8/8/2022 | Mizuho | Boost Target | Neutral | $95.00 ➝ $98.00 | |
8/5/2022 | Robert W. Baird | Boost Target | | $117.00 ➝ $125.00 | |
8/5/2022 | Barclays | Boost Target | Overweight | $110.00 ➝ $113.00 | |
7/15/2022 | Morgan Stanley | Boost Target | Equal Weight | $100.00 ➝ $102.00 | |
4/28/2022 | Wedbush | Reiterated Rating | Outperform | | |
4/12/2022 | Barclays | Boost Target | Overweight | $100.00 ➝ $110.00 | |
4/4/2022 | JPMorgan Chase & Co. | Boost Target | Overweight | $125.00 ➝ $126.00 | |
3/3/2022 | Jefferies Financial Group | Downgrade | Hold | $94.00 | |
3/3/2022 | Piper Sandler | Downgrade | Overweight ➝ Neutral | $114.00 ➝ $94.00 | |
2/24/2022 | The Goldman Sachs Group | Upgrade | Neutral ➝ Buy | $115.00 | |
2/14/2022 | HC Wainwright | Reiterated Rating | Buy | $140.00 | |
2/14/2022 | Morgan Stanley | Boost Target | Equal Weight | $95.00 ➝ $100.00 | |
2/14/2022 | Mizuho | Lower Target | | $103.00 ➝ $95.00 | |
2/11/2022 | Raymond James | Reiterated Rating | Buy | $125.00 | |
2/1/2022 | Morgan Stanley | Lower Target | Equal Weight | $103.00 ➝ $95.00 | |
1/26/2022 | Piper Sandler | Lower Target | | $123.00 ➝ $114.00 | |
1/20/2022 | Barclays | Lower Target | Overweight | $110.00 ➝ $100.00 | |
1/18/2022 | Royal Bank of Canada | Downgrade | Outperform ➝ Sector Perform | $122.00 ➝ $90.00 | |
1/7/2022 | HC Wainwright | Reiterated Rating | Buy | $140.00 | |
1/7/2022 | Morgan Stanley | Lower Target | Equal Weight | $112.00 ➝ $103.00 | |
12/8/2021 | HC Wainwright | Reiterated Rating | Buy | $139.00 | |
12/8/2021 | Oppenheimer | Boost Target | Outperform ➝ Outperform | $140.00 ➝ $154.00 | |
12/8/2021 | Citigroup | Boost Target | Buy ➝ Buy | $127.00 ➝ $129.00 | |
11/18/2021 | BMO Capital Markets | Initiated Coverage | Underperform | $76.00 | |
11/17/2021 | JPMorgan Chase & Co. | Upgrade | Neutral ➝ Overweight | $124.00 | |
11/2/2021 | Citigroup | Lower Target | Buy | $132.00 ➝ $127.00 | |
11/2/2021 | Raymond James | Lower Target | Outperform | $163.00 ➝ $150.00 | |
11/2/2021 | Royal Bank of Canada | Lower Target | Outperform | $130.00 ➝ $119.00 | |
11/2/2021 | Mizuho | Boost Target | Neutral | $99.00 ➝ $103.00 | |
11/2/2021 | Cantor Fitzgerald | Boost Target | Overweight | $117.00 ➝ $123.00 | |
10/18/2021 | Leerink Partners | Reiterated Rating | Market Perform | | |
10/14/2021 | Morgan Stanley | Downgrade | Overweight ➝ Equal Weight | $110.00 ➝ $112.00 | |
9/30/2021 | HC Wainwright | Reiterated Rating | Buy | | |
9/22/2021 | Needham & Company LLC | Initiated Coverage | Hold | | |
8/4/2021 | Morgan Stanley | Lower Target | Overweight | $116.00 ➝ $110.00 | |
7/16/2021 | HC Wainwright | Reiterated Rating | Buy | $140.00 | |
5/18/2021 | The Goldman Sachs Group | Initiated Coverage | Neutral | $108.00 | |
5/6/2021 | Wedbush | Lower Target | | $112.00 ➝ $107.00 | |
5/6/2021 | Oppenheimer | Lower Target | | $145.00 ➝ $140.00 | |
5/6/2021 | Morgan Stanley | Lower Target | Overweight | $125.00 ➝ $116.00 | |
5/6/2021 | Leerink Partners | Lower Target | Market Perform | $110.00 ➝ $100.00 | |
5/6/2021 | Barclays | Upgrade | Equal Weight ➝ Overweight | $110.00 | |
5/3/2021 | Mizuho | Lower Target | Neutral | $119.00 ➝ $116.00 | |
4/26/2021 | Mizuho | Lower Target | In-Line ➝ Neutral | $119.00 ➝ $116.00 | |
4/19/2021 | Morgan Stanley | Boost Target | Overweight | $121.00 ➝ $125.00 | |
4/12/2021 | Wedbush | Lower Target | Outperform | $126.00 ➝ $112.00 | |
3/5/2021 | Robert W. Baird | Reiterated Rating | Buy | | |
2/5/2021 | Mizuho | Boost Target | Neutral | $117.00 ➝ $119.00 | |
2/1/2021 | Raymond James | Initiated Coverage | Outperform | $163.00 ➝ $163.00 | |
1/26/2021 | William Blair | Reiterated Rating | Buy | | |
12/29/2020 | Cantor Fitzgerald | Lower Target | Overweight | $168.00 ➝ $121.00 | |
12/16/2020 | Morgan Stanley | Lower Target | Overweight | $133.00 ➝ $121.00 | |
12/7/2020 | Wedbush | Lower Target | Outperform | $129.00 ➝ $121.00 | |
11/10/2020 | Oppenheimer | Lower Target | | $150.00 ➝ $145.00 | |
11/10/2020 | Smith Barney Citigroup | Lower Target | | $149.00 ➝ $138.00 | |
11/10/2020 | William Blair | Reiterated Rating | Outperform | | |
11/10/2020 | Wedbush | Lower Target | Outperform | $147.00 ➝ $129.00 | |
11/10/2020 | Credit Suisse Group | Lower Target | Neutral | $105.00 ➝ $90.00 | |
11/10/2020 | Mizuho | Lower Target | Neutral | $132.00 ➝ $117.00 | |
11/10/2020 | Leerink Partners | Lower Target | Market Perform | $120.00 ➝ $100.00 | |
10/29/2020 | Oppenheimer | Lower Target | Outperform | $155.00 ➝ $150.00 | |
9/30/2020 | Benchmark | Initiated Coverage | Hold | | |
8/4/2020 | Credit Suisse Group | Lower Target | Neutral | $135.00 ➝ $126.00 | |
8/4/2020 | Morgan Stanley | Lower Target | Overweight | $149.00 ➝ $146.00 | |
8/4/2020 | HC Wainwright | Boost Target | Buy | $131.00 ➝ $140.00 | |
8/4/2020 | Cantor Fitzgerald | Boost Target | Overweight | $144.00 ➝ $161.00 | |
8/4/2020 | Mizuho | Boost Target | Neutral | $127.00 ➝ $132.00 | |
8/4/2020 | Leerink Partners | Boost Target | Market Perform | $105.00 ➝ $120.00 | |
8/4/2020 | Piper Sandler | Boost Target | Overweight | $141.00 ➝ $145.00 | |
8/4/2020 | JPMorgan Chase & Co. | Downgrade | Overweight ➝ Neutral | $136.00 | |
7/23/2020 | Mizuho | Boost Target | Neutral | $105.00 ➝ $127.00 | |
7/20/2020 | Credit Suisse Group | Boost Target | Neutral | $101.00 ➝ $135.00 | |
7/17/2020 | Oppenheimer | Boost Target | Outperform | $142.00 ➝ $152.00 | |
7/15/2020 | Morgan Stanley | Boost Target | Overweight | $120.00 ➝ $149.00 | |
6/29/2020 | The Goldman Sachs Group | Downgrade | Buy ➝ Neutral | $135.00 | |
6/26/2020 | Citigroup | Boost Target | Buy | $124.00 ➝ $149.00 | |
6/18/2020 | JPMorgan Chase & Co. | Boost Target | In-Line ➝ Overweight | $122.00 ➝ $134.00 | |
6/18/2020 | Royal Bank of Canada | Boost Target | Outperform | $116.00 ➝ $135.00 | |
6/17/2020 | HC Wainwright | Reiterated Rating | Buy | $125.00 ➝ $131.00 | |
6/16/2020 | Needham & Company LLC | Initiated Coverage | Hold | | |
6/16/2020 | Oppenheimer | Initiated Coverage | Buy | $142.00 | |
6/8/2020 | Wedbush | Initiated Coverage | Outperform | $147.00 | |
6/1/2020 | Piper Sandler | Reiterated Rating | Buy | $126.00 | |
5/7/2020 | Barclays | Boost Target | Equal Weight | $105.00 ➝ $108.00 | |
5/7/2020 | Mizuho | Boost Target | Neutral | $103.00 ➝ $105.00 | |
5/7/2020 | Morgan Stanley | Lower Target | Buy | $121.00 ➝ $120.00 | |
5/7/2020 | HC Wainwright | Reiterated Rating | Buy | $125.00 | |
5/7/2020 | Needham & Company LLC | Reiterated Rating | Hold | | |
4/30/2020 | William Blair | Reiterated Rating | Buy | | |
4/27/2020 | Needham & Company LLC | Reiterated Rating | Hold | | |
4/13/2020 | Oppenheimer | Lower Target | Outperform | $132.00 ➝ $130.00 | |
4/8/2020 | Piper Sandler | Lower Target | | $147.00 ➝ $125.00 | |
4/8/2020 | Needham & Company LLC | Reiterated Rating | Hold ➝ Neutral | | |
4/8/2020 | Royal Bank of Canada | Reiterated Rating | Buy | $104.00 | |
3/5/2020 | Citigroup | Initiated Coverage | Buy | $124.00 | |
2/27/2020 | Barclays | Initiated Coverage | Equal Weight | $105.00 | |
2/24/2020 | William Blair | Initiated Coverage | Outperform | $116.00 | |
2/14/2020 | Stifel Nicolaus | Reiterated Rating | Buy | $127.00 | |
2/5/2020 | Mizuho | Initiated Coverage | Neutral | $107.00 | |
2/5/2020 | HC Wainwright | Reiterated Rating | Buy | $102.00 ➝ $125.00 | |
1/20/2020 | Royal Bank of Canada | Reiterated Rating | Buy | $125.00 | |
1/17/2020 | Morgan Stanley | Boost Target | Overweight | $120.00 ➝ $121.00 | |
1/13/2020 | Oppenheimer | Boost Target | Outperform | $115.00 ➝ $132.00 | |
12/17/2019 | Morgan Stanley | Boost Target | Overweight | $110.00 ➝ $120.00 | |
12/13/2019 | Credit Suisse Group | Downgrade | Outperform ➝ Neutral | $110.00 | |
12/12/2019 | Piper Sandler Companies | Reiterated Rating | Overweight | $116.00 ➝ $153.00 | |
11/5/2019 | Piper Sandler Companies | Boost Target | | $111.00 ➝ $116.00 | |